Shu Taishen announced that the board of directors of the company recently received a written resignation report from Ms. Bai Xuelian, general manager of the Clinical Research Center. She applied to resign as general manager of the company's clinical research center due to personal reasons. The original term of office was until the end of the sixth board of directors of the company. The resignation report takes effect from the date it is delivered to the board of directors, and no longer holds any position in the company after the resignation. As of the disclosure date of the announcement, Ms. Bai Xuelian did not directly or indirectly hold the company's shares.

Shu Taishen announced that the board of directors of the company recently received a written resignation report from Ms. Bai Xuelian, general manager of the Clinical Research Center. She applied to resign as general manager of the company's clinical research center due to personal reasons. The original term of office was until the end of the sixth board of directors of the company. The resignation report takes effect from the date it is delivered to the board of directors, and no longer holds any position in the company after the resignation. As of the disclosure date of the announcement, Ms. Bai Xuelian did not directly or indirectly hold the company's shares.